IP protection

Oasmia established a comprehensive patent protection strategy for medicines formulated with XR-17™ that is independent of the API used.

In addition to its technology patents, Oasmia pursues an aggressive strategy of patent protection of its Intellectual Property in many jurisdictions in the world.